Earlier Clinical Insight
DTC’s Intake and Assessments Surface Chronic-Risk Signals Early.
Earlier Clinical Insight
DTC’s Intake and Assessments Surface Chronic-Risk Signals Early.
Every Patient. Earlier Insight. DTC helps providers gain earlier visibility into patient-reported health concerns, recognize potential care gaps, and support more informed clinical decisions across primary care,
Diabetes Testing Centers™ (DTC) was founded by former family practice owners who witnessed chronic diseases go unrecognized until preventable complications developed. Combining that experience with decades of leadership in healthcare and diagnostics, DTC has spent nearly two decades helping providers identify chronic health risks earlier through non-invasive assessments—without disrupting how they practice medicine.
Our mission has always centered on early identification of health risks. Diabetes is where our work began, but our vision has always reached further. Today, DTC brings that vision to life through proprietary patient intake that captures potential chronic-risk signals, followed by provider-directed, non-invasive risk assessments that help uncover concerns often missed during routine visits. Available in-clinic or remotely, our solutions support earlier clinical evaluation and informed decisions while minimizing disruption to existing workflows and demands on clinical staff.
By combining structured patient-reported intake with provider-directed clinical assessments, DTC helps practices recognize potential health concerns earlier, support informed clinical decisions, and address risks before preventable complications develop.
Patients often experience changes in their health that they rarely mention during routine visits—changes that may otherwise go unrecognized or undocumented.
DTC helps close this gap through proprietary, patient-administered digital intake and pre-screening models designed for pediatric through geriatric populations. These tools capture patient-reported changes across multiple clinical domains and organize them into structured summaries that give providers greater visibility into potential health concerns.
The principle is simple: “This is what the patient said.”
Our intake makes no diagnosis, establishes no medical necessity or billing determination, and recommends no testing or treatment. It is not a clinical assessment. The provider retains complete authority to interpret the information and determine whether further evaluation, diagnostic testing, monitoring, referral, or treatment is appropriate.
Chronic disease often develops gradually, with subtle changes in how patients feel, function, move, think, sleep, or manage everyday activities. Patients may attribute these changes to aging, stress, or fatigue—and never mention them unless asked in a structured, consistent manner.
DTC was founded by former family practice owners who witnessed firsthand how chronic conditions could go unrecognized until complications developed. Combined with decades of leadership in diabetes, medical diagnostics, and healthcare delivery, that experience shaped our mission: helping providers recognize potential health concerns earlier, without disrupting how they practice medicine.
DTC combines structured digital intake with focused, non-invasive clinical assessments that can be incorporated into existing practice workflows. Our approach is designed to minimize additional staffing, infrastructure, and administrative demands while supporting more informed clinical decisions.
With an established network reaching more than 20,000 independent medical practices nationwide, DTC helps bridge the gap between patient-reported concerns and provider-directed clinical evaluation. Our goal is not to replace clinical judgment, but to strengthen the information available to support it.
DTC was founded by former family practice owners who watched preventable chronic disease get recognized only after real damage had been done. Combined with decades of enterprise leadership in diabetes and diagnostics, that experience became a chronic-risk identification platform — designed to help practices see risk sooner without changing how they already practice.
Identify Signals Early
Early health concerns are not always apparent during routine visits. DTC's proprietary digital intake models provide a convenient, structured way for patients to report changes in their health, whether completed in the clinic, at home, or through remote outreach.
Designed as non-diagnostic pre-screeners, these models organize patient-reported information into concise summaries for provider review. They help bring potentially overlooked concerns to the provider's attention without interpreting findings, establishing medical necessity, or recommending clinical action. Providers retain complete authority to determine whether additional evaluation or follow-up is appropriate.
Adult Intake (18–64): Provides a broad, structured approach to capturing patient-reported health changes and potential chronic-risk signals, supporting more informed clinical encounters.
Geriatric Intake (65+): Addresses the added complexity of aging by organizing patient-reported changes that may otherwise be overlooked or attributed to normal aging, supporting provider awareness and continuity of care.
Our proprietary intake models support a comprehensive approach to early chronic-risk recognition, consistent with the American Heart Association's Cardiovascular-Kidney-Metabolic (CKM) health framework and broader preventive healthcare priorities—without replacing clinical assessment or independent medical judgment.
Find What Others Miss
The case for earlier identification is not theoretical—it is measurable and clinically meaningful. By capturing what patients may already be experiencing in a structured way at intake, practices give providers a clearer, better-documented starting point for evaluating whether follow-up assessment, monitoring, referral, or care planning is appropriate.
Chronic damage accumulates long before symptoms become obvious, leaving providers to intervene later, when care is more reactive, costly, and complex. The challenge is that most primary care workflows are not built to consistently capture risk during that earlier window. Patients present with a chief complaint, and providers respond to what is reported.
DTC is designed to close that gap. Its broader health-risk identification model helps identify patient-reported risk signals earlier and organize them for provider review, so clinicians can direct patients toward appropriate evaluation, follow-up, clinical services, or care-management pathways — across fee-for-service, ACO/VBC, and Medicare Advantage workflows.
The practices that benefit most are not adding complexity. They are seeing their existing patients more completely — using a structured pathway to surface risk earlier, document it clearly, and move patients toward timely, provider-directed care.
Turn Intake to Insight
For more than a decade, DTC has worked with providers on earlier identification of the most common chronic conditions through non-invasive assessment programs. That experience made one thing clear: chronic damage begins long before diagnosis, and the earliest indications are often things patients already notice and can report.
Our proprietary intake models were built from that experience—a patient-administered intake screener that captures structured patient-reported risk signals before the provider encounter and organizes them for review, so providers can determine where focused screening, testing, referral, follow-up, or care-management consideration may be appropriate.
Getting Started Is Simple:
Start with our proprietary intake
Identify structured patient-reported risk signals early and consistently.
Review Patient-Reported Risk Signals
See where patients may benefit from further provider evaluation, and where focused screening, testing, referral, follow-up, or care-management consideration may be appropriate.
Prioritize the Highest-Impact Pathways First
Some patients may require next-step review immediately, while broader clinic trends often become clearer within the first 30 to 90 days of consistent use.
Every Signal Counts